Enanta Pharmaceuticals
ENTA
ENTA
100 hedge funds and large institutions have $287M invested in Enanta Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 44
27% less capital invested
Capital invested by funds: $391M → $287M (-$104M)
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
Holders
100
Holding in Top 10
2
Calls
$140K
Puts
$68K
Top Buyers
| 1 | +$5.32M | |
| 2 | +$2.84M | |
| 3 | +$2.4M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
+$1.64M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$1.23M |
Top Sellers
| 1 | -$7.63M | |
| 2 | -$2.04M | |
| 3 | -$1.82M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.14M |
| 5 |
Two Sigma Investments
New York
|
-$944K |